NCT01466257View on ClinicalTrials.gov

Biomarkers in Patients With Head and Neck Cancer

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

November 21, 2011

Primary Completion Date

January 1, 2012

Study Completion Date

January 1, 2012

Conditions
Head and Neck Cancer
Interventions
BIOLOGICAL

cetuximab

DRUG

cisplatin

GENETIC

DNA analysis

GENETIC

gene expression analysis

GENETIC

mutation analysis

OTHER

laboratory biomarker analysis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

ECOG-ACRIN Cancer Research Group

NETWORK

NCT01466257 - Biomarkers in Patients With Head and Neck Cancer | Biotech Hunter | Biotech Hunter